- Home
- RDY vs CRTO Comparison
RDY vs CRTO Comparison
Compare RDY & CRTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDY
- CRTO
- Stock Information
- Founded
- RDY 1984
- CRTO 2005
- Country
- RDY India
- CRTO France
- Employees
- RDY N/A
- CRTO N/A
- Industry
- RDY Biotechnology: Pharmaceutical Preparations
- CRTO Advertising
- Sector
- RDY Health Care
- CRTO Consumer Discretionary
- Exchange
- RDY Nasdaq
- CRTO Nasdaq
- Market Cap
- RDY 2.1B
- CRTO 2.1B
- IPO Year
- RDY N/A
- CRTO 2013
- Fundamental
- Price
- RDY $13.24
- CRTO $35.65
- Analyst Decision
- RDY Buy
- CRTO Buy
- Analyst Count
- RDY 1
- CRTO 10
- Target Price
- RDY $17.00
- CRTO $54.67
- AVG Volume (30 Days)
- RDY 1.9M
- CRTO 340.4K
- Earning Date
- RDY 05-06-2025
- CRTO 05-01-2025
- Dividend Yield
- RDY 3.63%
- CRTO N/A
- EPS Growth
- RDY 2.68
- CRTO 115.91
- EPS
- RDY 0.75
- CRTO 1.90
- Revenue
- RDY $3,637,607,642.00
- CRTO $1,933,289,000.00
- Revenue This Year
- RDY $17.23
- CRTO N/A
- Revenue Next Year
- RDY $9.19
- CRTO $7.82
- P/E Ratio
- RDY $17.88
- CRTO $18.74
- Revenue Growth
- RDY 14.74
- CRTO N/A
- 52 Week Low
- RDY $12.50
- CRTO $33.15
- 52 Week High
- RDY $16.89
- CRTO $49.93
- Technical
- Relative Strength Index (RSI)
- RDY 48.15
- CRTO 42.00
- Support Level
- RDY $13.10
- CRTO $33.93
- Resistance Level
- RDY $13.85
- CRTO $36.06
- Average True Range (ATR)
- RDY 0.13
- CRTO 1.48
- MACD
- RDY 0.02
- CRTO 0.10
- Stochastic Oscillator
- RDY 50.00
- CRTO 37.80
About RDY Dr. Reddy's Laboratories Ltd
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
About CRTO Criteo S.A.
Criteo SA is an ad-tech company in the digital advertising market. Its technology, allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. The firm also provides technology allowing retailers to effectively manage their ad inventories and improve yield optimization.